1h Free Analyst Time
Global Single-Photon Emission Computed Tomography (SPECT) Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the single-photon emission computed tomography (SPECT) market and it is poised to grow by $ 620.21 mn during 2020-2024, progressing at a CAGR of 6% during the forecast period. The reports on the single-photon emission computed tomography (SPECT) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing adoption of SPECT/CT hybrid imaging systems and the rise in the prevalence of chronic disorders. In addition, the growing adoption of SPECT/CT hybrid imaging systems is anticipated to boost the growth of the market as well.
The single-photon emission computed tomography (SPECT) market analysis includes product segment, application segment and geographical landscapes.
The single-photon emission computed tomography (SPECT) market is segmented as below:
By Product
- Standalone SPECT
- Hybrid SPECT
By Application
- Cardiology
- Oncology
- Neurology
- Others
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the increased use of nuclear medicine for detecting diseases at an early stage as one of the prime reasons driving the single-photon emission computed tomography (SPECT) market growth during the next few years.
The single-photon emission computed tomography (SPECT) market report covers the following areas:
- Single-photon emission computed tomography (SPECT) market sizing
- Single-photon emission computed tomography (SPECT) market forecast
- Single-photon emission computed tomography (SPECT) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading single-photon emission computed tomography (SPECT) market vendors that include Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc. Also, the single-photon emission computed tomography (SPECT) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market Segmentation by Application
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibit
Executive Summary
The publisher recognizes the following companies as the key players in the global single-photon emission computed tomography (spect) market: Bruker Corp., DDD-Diagnostic AS, Digirad Corp., General Electric Co., Koninklijke Philips NV, Mediso Ltd., MiE GmbH, MILabs BV, Siemens Healthineers AG, and Spectrum Dynamics Medical Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increased use of nuclear medicine for detecting diseases at an early stage.'
According to the report, one of the major drivers for this market is the growing adoption of spect/ct hybrid imaging systems.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bruker Corp.
- DDD-Diagnostic AS
- Digirad Corp.
- General Electric Co.
- Koninklijke Philips NV
- Mediso Ltd.
- MiE GmbH
- MILabs BV
- Siemens Healthineers AG
- Spectrum Dynamics Medical Inc.